Live Breaking News & Updates on Georgina Mowatt

Stay updated with breaking news from Georgina mowatt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer

- Oral presentation based on Late-breaking Abstract featured at American Urological Association's 2022 Annual Meeting (AUA2022) - Blue Earth Diagnostics, a Bracco company and recognized leader in ....

United States , United Kingdom , Scintomics Gmb , Kostenloser Wertpapierhandel , Georgina Mowatt , Markt Fleming , Davide Gauden , Mike Beyer , Priscilla Harlan , Study Group , Drug Administration , American Urological Association , Sam Brown Inc , Bracco Group , Technical University Of Munich , Virginia Oncology Associates , Us Oncology Research , Nuclear Medicine , Corporate Communications , Late Breaking Abstract , Earth Diagnostics , Prostate Specific Membrane Antigen Targeted , True Positive , New Drug Application , Chief Executive Officer , Blue Earth ,

Blue Earth Therapeutics Announces U.S. FDA Clearance for Investigational New Drug (IND) Application

− 177Lutetium-labelled radiohybrid Prostate-Specific Membrane Antigen (177Lu-rhPSMA-10.1) is a highly optimized, next generation therapeutic radiopharmaceutical −− Newly launched Blue Earth Therapeutics rapidly advancing lead candidate into Phase 1/2 clinical development –OXFORD, United Kingdom & BURLINGTON, Mass. . ....

United States , United Kingdom , Scintomics Gmb , Georgina Mowatt , Davide Gauden , Mike Beyer , Priscilla Harlan , Company Investigational New Drug Application , Drug Administration , Sam Brown Inc , Bracco Group , Technical University Of Munich , Nuclear Medicine , Corporate Communications , Prostate Specific Membrane Antigen , Blue Earth Therapeutics , Investigational New Drug Application , Blue Earth Therapeutic , Earth Therapeutics , Chief Executive Officer , Radiohybrid Prostate Specific Membrane Antigen , Prostate Specific Membrane Antigen Targeted , Technical University , Blue Earth Diagnostics , Scintomics Gmbh , Blue Earth ,

Blue Earth Diagnostics Announces Key Results from Phase 3 SPOTLIGHT Study of 18F-rhPSMA-7.3, an Investigational PET Imaging Agent, in Biochemical Recurrence of Prostate Cancer

BURLINGTON, Mass. & OXFORD, England (BUSINESS WIRE) Feb 15, 2022 ....

United States , United Kingdom , David Gauden , Scintomics Gmb , Georgina Mowatt , Davidm Schuster , Mike Beyer , Priscilla Harlan , Emory University School Of Medicine , Drug Administration , Winship Cancer Institute Of Emory University , Sam Brown Inc , Bracco Group , Technical University Of Munich , Nuclear Medicine , Corporate Communications , Earth Diagnostics , Cancers Symposium , Prostate Specific Membrane Antigen Targeted , Blue Earth , Winship Cancer Institute , Emory University , Emory University School , Coordinating Investigator , Chief Scientific Officer , New Drug Application ,

Blue Earth Diagnostics Highlights Upcoming Presentation of Key Results from Phase 3 SPOTLIGHT Study of Targeted PET Imaging Agent 18F-rhPSMA-7.3 in Biochemically Recurrent Prostate Cancer

BURLINGTON, Mass. & OXFORD, England (BUSINESS WIRE) Feb 1, 2022 ....

United States , United Kingdom , San Francisco , Scintomics Gmb , Georgina Mowatt , Davidm Schuster , Mike Beyer , Priscilla Harlan , Winship Cancer Institute Of Emory University , Sam Brown Inc , Bracco Group , Technical University Of Munich , Nuclear Medicine , Corporate Communications , Blue Earth Diagnostic Medical Affairs , Earth Diagnostics , Cancers Symposium , Prostate Specific Membrane Antigen Targeted , Detection Rates , Suspected Prostate Cancer Recurrence , Multicenter Study , Winship Cancer Institute , Emory University , General Session , Multidisciplinary Management Across , Radiohybrid Prostate Specific Membrane Antigen ,

Blue Earth Diagnostics Highlights Axumin (Fluciclovine F 18) Presentation at Upcoming 22nd Annual Scientific Meeting in Urologic Oncology (SUO)

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced a presentation on Axumin (fluciclovine ....

United Kingdom , Kostenloser Wertpapierhandel , Georgina Mowatt , Geraldl Andriole , Mike Beyer , Priscilla Harlan , Division Of Urologic Surgery , Society Of Urologic Oncology , Alvinj Siteman Cancer Center , Washington University School Of Medicine , Department Of Surgery , Sam Brown Inc , Bracco Group , Nuclear Medicine , Corporate Communications , Blue Earth Diagnostics , Annual Scientific Meeting , Urologic Oncology , Biochemical Recurrence , Prostate Cancer , Data Analysis , Two Prospective Clinical , Urologic Surgery , Cancer Center , Washington University School , Earth Diagnostics ,